Evidence map›Paper›PMID 36084031›Full record

ArticlePloS one2022

The mosquito vectors that sustained malaria transmission during the Magude project despite the combined deployment of indoor residual spraying, insecticide-treated nets and mass-drug administration.

Lucía Fernández Montoya, Helena Martí-Soler, Mara Máquina, Kiba Comiche, Inocencia Cuamba, Celso Alafo, Lizette L Koekemoer, Ellie Sherrard-Smith, Quique Bassat, Beatriz Galatas and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 5 countries.

Lucía Fernández MontoyaISGlobal, Barcelona, Spain.ORCID 0000-0001-6764-6592
Helena Martí-SolerISGlobal, Barcelona, Spain.
Mara MáquinaCentro de Investigação em Saúde de Manhiça (CISM), Fundação Manhiça, Mozambique.
Kiba ComicheCentro de Investigação em Saúde de Manhiça (CISM), Fundação Manhiça, Mozambique.
Inocencia CuambaCentro de Investigação em Saúde de Manhiça (CISM), Fundação Manhiça, Mozambique.
Celso AlafoCentro de Investigação em Saúde de Manhiça (CISM), Fundação Manhiça, Mozambique.
Lizette L KoekemoerFaculty of Health Sciences, WITS Research Institute for Malaria, University of the Witswatersrand and the Natitonal Institute for Communicable Diseases, Johannesburg, South Africa.ORCID 0000-0003-4236-6345
Ellie Sherrard-SmithMRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom.ORCID 0000-0001-8317-7992
Quique BassatISGlobal, Barcelona, Spain.
Beatriz GalatasISGlobal, Barcelona, Spain.
Pedro AideCentro de Investigação em Saúde de Manhiça (CISM), Fundação Manhiça, Mozambique.
Nelson CuambaPrograma Nacional de Controlo da Malária, Ministério da Saúde, Maputo, Mozambique.
Dulcisaria JotamoPrograma Nacional de Controlo da Malária, Ministério da Saúde, Maputo, Mozambique.
Francisco SaúteCentro de Investigação em Saúde de Manhiça (CISM), Fundação Manhiça, Mozambique.
Krijn P PaaijmansISGlobal, Barcelona, Spain.
Manhiça Health Research Centre · MZInstituto Nacional de Saúde · MZBarcelona Institute for Global Health · ESImperial College London · GBInstitució Catalana de Recerca i Estudis Avançats · ESUniversity of the Witwatersrand · ZA

Funding

Medical Research Council MR/R015600/1Medical Research Council MR/T041986/1
6 · The paper itself

Abstract

The "Magude project" aimed but failed to interrupt local malaria transmission in Magude district, southern Mozambique, by using a comprehensive package of interventions, including indoor residual spraying (IRS), pyrethroid-only long-lasting insecticide treated nets (LLINs) and mass-drug administration (MDA). Here we present detailed information on the vector species that sustained malaria transmission, their association with malaria incidence and behaviors, and their amenability to the implemented control interventions. Mosquitoes were collected monthly between May 2015 and October 2017 in six sentinel sites in Magude district, using CDC light traps both indoors and outdoors. Anopheles arabiensis was the main vector during the project, while An. funestus s.s., An. merus, An. parensis and An. squamosus likely played a secondary role. The latter two species have never previously been found positive for Plasmodium falciparum in southern Mozambique. The intervention package successfully reduced vector sporozoite rates in all species throughout the project. IRS was effective in controlling An. funestus s.s. and An. parensis, which virtually disappeared after its first implementation, but less effective at controlling An. arabiensis. Despite suboptimal use, LLINs likely provided significant protection against An. arabiensis and An. merus that sought their host largely indoors when people where in bed. Adding IRS on top of LLINs and MDA likely added value to the control of malaria vectors during the Magude project. Future malaria elimination attempts in the area could benefit from i) increasing the use of LLINs, ii) using longer-lasting IRS products to counteract the increase in vector densities observed towards the end of the high transmission season, and iii) a higher coverage with MDA to reduce the likelihood of human infection. However, additional interventions targeting vectors that survive IRS and LLINs by biting outdoors or indoors before people go to bed, will be likely needed to achieve local malaria elimination.

Indexed as

AnophelesInsecticidesInsecticide-Treated BednetsMalariaPyrethrinsAnimalsHumansMosquito ControlMosquito VectorsInsecticidesPyrethrins

Identifiers

PMID36084031
PMCPMC9462736
OpenAlexW4295048444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.